Bevacizumab attenuates major signaling cascades and eIF4E translation initiation factor in multiple myeloma cells.

Bevacizumab attenuates major signaling cascades and eIF4E translation initiation factor in multiple myeloma cells.

Item
http://www.wikidata.org/entity/Q39443134
CXCR7-dependent angiogenic mononuclear cell trafficking regulates tumor progression in multiple myeloma.Silica nanoparticles enhance autophagic activity, disturb endothelial cell homeostasis and impair angiogenesis.Activity of everolimus (RAD001) in relapsed and/or refractory multiple myeloma: a phase I study.eIF4E and eIF4GI have distinct and differential imprints on multiple myeloma's proteome and signaling.Phospho-4e-BP1 and eIF4E overexpression synergistically drives disease progression in clinically confined clear cell renal cell carcinomaDiscovering discovery patterns with Predication-based Semantic Indexing.Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma.Microvesicles derived from normal and multiple myeloma bone marrow mesenchymal stem cells differentially modulate myeloma cells' phenotype and translation initiation.Monoclonal antibody therapy in multiple myeloma: where do we stand and where are we going?Migration and epithelial-to-mesenchymal transition of lung cancer can be targeted via translation initiation factors eIF4E and eIF4GI.Multiple myeloma and bone marrow mesenchymal stem cells' crosstalk: Effect on translation initiation.Inhibition of mTOR with everolimus and silencing by vascular endothelial cell growth factor-specific siRNA induces synergistic antitumor activity in multiple myeloma cells.Secretome of human bone marrow mesenchymal stem cells: an emerging player in lung cancer progression and mechanisms of translation initiation.
P2860

Bevacizumab attenuates major signaling cascades and eIF4E translation initiation factor in multiple myeloma cells.

Item
http://www.wikidata.org/entity/Q39443134
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Bevacizumab attenuates major s ...... tor in multiple myeloma cells.
@en
Bevacizumab attenuates major s ...... tor in multiple myeloma cells.
@nl
type
label
Bevacizumab attenuates major s ...... tor in multiple myeloma cells.
@en
Bevacizumab attenuates major s ...... tor in multiple myeloma cells.
@nl
prefLabel
Bevacizumab attenuates major s ...... tor in multiple myeloma cells.
@en
Bevacizumab attenuates major s ...... tor in multiple myeloma cells.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Bevacizumab attenuates major s ...... tor in multiple myeloma cells.
@en
P2093
P2860
P2888
P304
P31
P356
10.1038/LABINVEST.2011.162
P433
P478
P577
P5875
P698
P921